Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Flurbiprofen sodium microparticles and soft pellets for nose-to-brain delivery: Serum and brain levels in rats after nasal insufflation.
Tiozzo Fasiolo L, Manniello MD, Banella S, Napoli L, Bortolotti F, Quarta E, Colombo P, Balafas E, Kostomitsopoulos N, Rekkas DM, Valsami G, Papakyriakopoulou P, Colombo G, Russo P. Tiozzo Fasiolo L, et al. Among authors: banella s. Int J Pharm. 2021 Aug 10;605:120827. doi: 10.1016/j.ijpharm.2021.120827. Epub 2021 Jun 24. Int J Pharm. 2021. PMID: 34171428
Preparation and Biophysical Characterization of Quercetin Inclusion Complexes with β-Cyclodextrin Derivatives to be Formulated as Possible Nose-to-Brain Quercetin Delivery Systems.
Manta K, Papakyriakopoulou P, Chountoulesi M, Diamantis DA, Spaneas D, Vakali V, Naziris N, Chatziathanasiadou MV, Andreadelis I, Moschovou K, Athanasiadou I, Dallas P, Rekkas DM, Demetzos C, Colombo G, Banella S, Javornik U, Plavec J, Mavromoustakos T, Tzakos AG, Valsami G. Manta K, et al. Among authors: banella s. Mol Pharm. 2020 Nov 2;17(11):4241-4255. doi: 10.1021/acs.molpharmaceut.0c00672. Epub 2020 Oct 19. Mol Pharm. 2020. PMID: 32986435
Nasal powders of quercetin-β-cyclodextrin derivatives complexes with mannitol/lecithin microparticles for Nose-to-Brain delivery: In vitro and ex vivo evaluation.
Papakyriakopoulou P, Manta K, Kostantini C, Kikionis S, Banella S, Ioannou E, Christodoulou E, Rekkas DM, Dallas P, Vertzoni M, Valsami G, Colombo G. Papakyriakopoulou P, et al. Among authors: banella s. Int J Pharm. 2021 Sep 25;607:121016. doi: 10.1016/j.ijpharm.2021.121016. Epub 2021 Aug 16. Int J Pharm. 2021. PMID: 34411652
Nasal delivery as a strategy for the prevention and treatment of COVID-19.
Sonvico F, Colombo G, Quarta E, Guareschi F, Banella S, Buttini F, Scherließ R. Sonvico F, et al. Among authors: banella s. Expert Opin Drug Deliv. 2023 Jul-Dec;20(8):1115-1130. doi: 10.1080/17425247.2023.2263363. Epub 2023 Oct 16. Expert Opin Drug Deliv. 2023. PMID: 37755135 Review.
Comparative Serum and Brain Pharmacokinetics of Quercetin after Oral and Nasal Administration to Rats as Lyophilized Complexes with β-Cyclodextrin Derivatives and Their Blends with Mannitol/Lecithin Microparticles.
Manta K, Papakyriakopoulou P, Nikolidaki A, Balafas E, Kostomitsopoulos N, Banella S, Colombo G, Valsami G. Manta K, et al. Among authors: banella s. Pharmaceutics. 2023 Jul 28;15(8):2036. doi: 10.3390/pharmaceutics15082036. Pharmaceutics. 2023. PMID: 37631250 Free PMC article.
12 results